BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32048344)

  • 1. Treatment of invasive fungal infections in intensive care units with micafungin: The MYRIADE study.
    Timsit JF; Leverger G; Milpied N; Gachot B
    Mycoses; 2020 May; 63(5):443-451. PubMed ID: 32048344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study.
    Leverger G; Timsit JF; Milpied N; Gachot B
    Pediatr Infect Dis J; 2019 Jul; 38(7):716-721. PubMed ID: 31192976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
    van der Geest PJ; Hunfeld NG; Ladage SE; Groeneveld AB
    BMC Infect Dis; 2016 Sep; 16():490. PubMed ID: 27634140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and Tolerability of Micafungin in Chinese Patients with Invasive Fungal Infections: A Retrospective, Multicenter Study.
    Zheng X; Huang X; Luo J; Li J; Li W; Liu Q; Niu T; Wang X; Zhou J; Zhang X; Hu J; Liu K
    Adv Ther; 2018 Sep; 35(9):1400-1410. PubMed ID: 30105657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study.
    Viscoli C; Bassetti M; Castagnola E; Cesaro S; Menichetti F; Ratto S; Tascini C; Giacobbe DR
    BMC Infect Dis; 2014 Dec; 14():725. PubMed ID: 25551699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
    Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
    Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micafungin for Candida infections in Slovenia and Romania: A multicenter, observational, prospective study.
    Zver S; Avcin S; Bedreag O; Bizilj S; Ecrulj V; Jazbec J; Puconja N; Stanic R; Jereb M
    J Infect Dev Ctries; 2021 Jun; 15(6):877-888. PubMed ID: 34242200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
    Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
    Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
    JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Dose Micafungin in Neonates and Young Infants with Invasive Candidiasis: Results of a Phase 2 Study.
    Auriti C; Goffredo BM; Ronchetti MP; Piersigilli F; Cairoli S; Bersani I; Dotta A; Bagolan P; Pai MP
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of micafungin sodium on fungal infection in critical care].
    Tateishi Y; Hirasawa H; Oda S; Nakanishi K; Kitamura S; Aikawa N
    Nihon Ishinkin Gakkai Zasshi; 2006; 47(4):293-7. PubMed ID: 17086162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
    Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
    BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Fungal Infections in the Intensive Care Unit.
    Ostrosky-Zeichner L; Al-Obaidi M
    Infect Dis Clin North Am; 2017 Sep; 31(3):475-487. PubMed ID: 28687215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders.
    Tamura K; Urabe A; Yoshida M; Kanamaru A; Kodera Y; Okamoto S; Maesaki S; Masaoka T
    Leuk Lymphoma; 2009 Jan; 50(1):92-100. PubMed ID: 19172498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical factors affecting costs in patients receiving systemic antifungal therapy in intensive care units in Greece: Results from the ESTIMATOR study.
    Armaganidis A; Nanas S; Antoniadou E; Mandragos K; Liakou K; Koutsoukou A; Baltopoulos G; Nakos G; Kounougeri A; Ganas K; Prekates A; Kompoti M; Georgopoulos D; Pneumatikos I; Zakynthinos E
    Mycoses; 2017 Jul; 60(7):454-461. PubMed ID: 28425571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the use of micafungin in newborns].
    Çakır SÇ; Çelebi S; Özkan H; Köksal N; Dorum BA; Yeşil E; Hacımustafaoğlu M
    Mikrobiyol Bul; 2019 Jan; 53(1):70-80. PubMed ID: 30683041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM; van der Elst KC; Veringa A; Jongedijk EM; Brüggemann RJ; Koster RA; Kampinga GA; Kosterink JG; van der Werf TS; Zijlstra JG; Touw DJ; Alffenaar JWC
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.
    Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M
    Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.